Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development

Dezheng Dong, Min Ni, Jianze Li, Shigang Xiong, Wei Ye, Jenilyn J. Virrey, Changhui Mao, Risheng Ye, Miao Wang, Ligaya Pen, Louis Dubeau, Susan Groshen, Florence M. Hofman, Amy S. Lee

Research output: Contribution to journalArticle

273 Citations (Scopus)

Abstract

The unfolded protein response (UPR) is an evolutionarily conserved mechanism that activates both proapoptotic and survival pathways to allow eukaryotic cells to adapt to endoplasmic reticulum (ER) stress. Although the UPR has been implicated in tumorigenesis, its precise role in endogenous cancer remains unclear. A major UPR protective response is the induction of the ER chaperone GRP78/BiP, which is expressed at high levels in a variety of tumors and confers drug resistance in both proliferating and dormant cancer cells. To determine the physiologic role of GRP78 in in situ-generated tumor and the consequence of its suppression on normal organs,we used a genetic model of breast cancer in the Grp78 heterozygous mice where GRP78 expression level was reduced by about half, mimicking anti-GRP78 agents that achieve partial suppression of GRP78 expression. Here, we report that Grp78 heterozygosity has no effect on organ development or antibody production but prolongs the latency period and significantly impedes tumor growth. Our results reveal three major mechanisms mediated by GRP78 for cancer progression: enhancement of tumor cell proliferation, protection against apoptosis, and promotion of tumor angiogenesis. Importantly, although partial reduction of GRP78 in the Grp78 heterozygous mice substantially reduces the tumor microvessel density, it has no effect on vasculature of normal organs. Our findings establish that a key UPR target GRP78 is preferably required for pathophysiologic conditions, such as tumor proliferation, survival, and angiogenesis, under-scoring its potential value as a novel therapeutic target for dual antitumor and antiangiogenesis activity.

Original languageEnglish (US)
Pages (from-to)498-505
Number of pages8
JournalCancer Research
Volume68
Issue number2
DOIs
StatePublished - Jan 15 2008

Fingerprint

Transgenes
Breast Neoplasms
Unfolded Protein Response
Neoplasms
Endoplasmic Reticulum Stress
Cytoprotection
Genetic Models
Eukaryotic Cells
Microvessels
Drug Resistance
Endoplasmic Reticulum
Antibody Formation
Carcinogenesis
Cell Proliferation
Apoptosis
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. / Dong, Dezheng; Ni, Min; Li, Jianze; Xiong, Shigang; Ye, Wei; Virrey, Jenilyn J.; Mao, Changhui; Ye, Risheng; Wang, Miao; Pen, Ligaya; Dubeau, Louis; Groshen, Susan; Hofman, Florence M.; Lee, Amy S.

In: Cancer Research, Vol. 68, No. 2, 15.01.2008, p. 498-505.

Research output: Contribution to journalArticle

Dong, D, Ni, M, Li, J, Xiong, S, Ye, W, Virrey, JJ, Mao, C, Ye, R, Wang, M, Pen, L, Dubeau, L, Groshen, S, Hofman, FM & Lee, AS 2008, 'Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development', Cancer Research, vol. 68, no. 2, pp. 498-505. https://doi.org/10.1158/0008-5472.CAN-07-2950
Dong, Dezheng ; Ni, Min ; Li, Jianze ; Xiong, Shigang ; Ye, Wei ; Virrey, Jenilyn J. ; Mao, Changhui ; Ye, Risheng ; Wang, Miao ; Pen, Ligaya ; Dubeau, Louis ; Groshen, Susan ; Hofman, Florence M. ; Lee, Amy S. / Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. In: Cancer Research. 2008 ; Vol. 68, No. 2. pp. 498-505.
@article{41d24879627a4f2f8f839fb88db8c66d,
title = "Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development",
abstract = "The unfolded protein response (UPR) is an evolutionarily conserved mechanism that activates both proapoptotic and survival pathways to allow eukaryotic cells to adapt to endoplasmic reticulum (ER) stress. Although the UPR has been implicated in tumorigenesis, its precise role in endogenous cancer remains unclear. A major UPR protective response is the induction of the ER chaperone GRP78/BiP, which is expressed at high levels in a variety of tumors and confers drug resistance in both proliferating and dormant cancer cells. To determine the physiologic role of GRP78 in in situ-generated tumor and the consequence of its suppression on normal organs,we used a genetic model of breast cancer in the Grp78 heterozygous mice where GRP78 expression level was reduced by about half, mimicking anti-GRP78 agents that achieve partial suppression of GRP78 expression. Here, we report that Grp78 heterozygosity has no effect on organ development or antibody production but prolongs the latency period and significantly impedes tumor growth. Our results reveal three major mechanisms mediated by GRP78 for cancer progression: enhancement of tumor cell proliferation, protection against apoptosis, and promotion of tumor angiogenesis. Importantly, although partial reduction of GRP78 in the Grp78 heterozygous mice substantially reduces the tumor microvessel density, it has no effect on vasculature of normal organs. Our findings establish that a key UPR target GRP78 is preferably required for pathophysiologic conditions, such as tumor proliferation, survival, and angiogenesis, under-scoring its potential value as a novel therapeutic target for dual antitumor and antiangiogenesis activity.",
author = "Dezheng Dong and Min Ni and Jianze Li and Shigang Xiong and Wei Ye and Virrey, {Jenilyn J.} and Changhui Mao and Risheng Ye and Miao Wang and Ligaya Pen and Louis Dubeau and Susan Groshen and Hofman, {Florence M.} and Lee, {Amy S.}",
year = "2008",
month = "1",
day = "15",
doi = "10.1158/0008-5472.CAN-07-2950",
language = "English (US)",
volume = "68",
pages = "498--505",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development

AU - Dong, Dezheng

AU - Ni, Min

AU - Li, Jianze

AU - Xiong, Shigang

AU - Ye, Wei

AU - Virrey, Jenilyn J.

AU - Mao, Changhui

AU - Ye, Risheng

AU - Wang, Miao

AU - Pen, Ligaya

AU - Dubeau, Louis

AU - Groshen, Susan

AU - Hofman, Florence M.

AU - Lee, Amy S.

PY - 2008/1/15

Y1 - 2008/1/15

N2 - The unfolded protein response (UPR) is an evolutionarily conserved mechanism that activates both proapoptotic and survival pathways to allow eukaryotic cells to adapt to endoplasmic reticulum (ER) stress. Although the UPR has been implicated in tumorigenesis, its precise role in endogenous cancer remains unclear. A major UPR protective response is the induction of the ER chaperone GRP78/BiP, which is expressed at high levels in a variety of tumors and confers drug resistance in both proliferating and dormant cancer cells. To determine the physiologic role of GRP78 in in situ-generated tumor and the consequence of its suppression on normal organs,we used a genetic model of breast cancer in the Grp78 heterozygous mice where GRP78 expression level was reduced by about half, mimicking anti-GRP78 agents that achieve partial suppression of GRP78 expression. Here, we report that Grp78 heterozygosity has no effect on organ development or antibody production but prolongs the latency period and significantly impedes tumor growth. Our results reveal three major mechanisms mediated by GRP78 for cancer progression: enhancement of tumor cell proliferation, protection against apoptosis, and promotion of tumor angiogenesis. Importantly, although partial reduction of GRP78 in the Grp78 heterozygous mice substantially reduces the tumor microvessel density, it has no effect on vasculature of normal organs. Our findings establish that a key UPR target GRP78 is preferably required for pathophysiologic conditions, such as tumor proliferation, survival, and angiogenesis, under-scoring its potential value as a novel therapeutic target for dual antitumor and antiangiogenesis activity.

AB - The unfolded protein response (UPR) is an evolutionarily conserved mechanism that activates both proapoptotic and survival pathways to allow eukaryotic cells to adapt to endoplasmic reticulum (ER) stress. Although the UPR has been implicated in tumorigenesis, its precise role in endogenous cancer remains unclear. A major UPR protective response is the induction of the ER chaperone GRP78/BiP, which is expressed at high levels in a variety of tumors and confers drug resistance in both proliferating and dormant cancer cells. To determine the physiologic role of GRP78 in in situ-generated tumor and the consequence of its suppression on normal organs,we used a genetic model of breast cancer in the Grp78 heterozygous mice where GRP78 expression level was reduced by about half, mimicking anti-GRP78 agents that achieve partial suppression of GRP78 expression. Here, we report that Grp78 heterozygosity has no effect on organ development or antibody production but prolongs the latency period and significantly impedes tumor growth. Our results reveal three major mechanisms mediated by GRP78 for cancer progression: enhancement of tumor cell proliferation, protection against apoptosis, and promotion of tumor angiogenesis. Importantly, although partial reduction of GRP78 in the Grp78 heterozygous mice substantially reduces the tumor microvessel density, it has no effect on vasculature of normal organs. Our findings establish that a key UPR target GRP78 is preferably required for pathophysiologic conditions, such as tumor proliferation, survival, and angiogenesis, under-scoring its potential value as a novel therapeutic target for dual antitumor and antiangiogenesis activity.

UR - http://www.scopus.com/inward/record.url?scp=39049160268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049160268&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-07-2950

DO - 10.1158/0008-5472.CAN-07-2950

M3 - Article

C2 - 18199545

AN - SCOPUS:39049160268

VL - 68

SP - 498

EP - 505

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 2

ER -